Skip to main content
. 2017 May 2;2(2):e000172. doi: 10.1136/esmoopen-2017-000172

Table 4.

Clinical scenarios and potential genetic cancer syndrome

Clinical picture, patient with a history or diagnosis of (synchronous or metachronous) Familial cancer syndrome to think of Full picture of familial cancer syndrome
Synchronous bilateral breast cancer or secondary (metachronous) breast cancer Hereditary breast and ovarian cancer (HBOC) [BRCA1, BRCA2] •Breast cancer
•Ovarian cancer
Breast and ovarian cancers HBOC [BRCA 1/2] •Male breast cancer
Prostate cancer and pancreatic cancer or melanoma HBOC [BRCA 2] •Prostate cancer
•Melanoma
(Multiple) renal cell carcinomas VHL •Renal cell carcinoma <47 years
Renal cell carcinoma and pancreatic cystic lesions VHL •Multiple renal cysts
Haemangioblastomas of central nervous system (CNS) and retina VHL •Multiple pancreas cysts and pancreatic neuroendocrine tumour
•CNS and retinal haemagioblastomas
•Phaeochromocytomas
•Endolymphatic sac tumours
•Cystadenomas of epididymis or broad ligament
Breast cancer and sarcoma Li-Fraumeni syndrome •Soft tissue sarcoma and osteosarcoma
Breast cancer and leukaemia Li-Fraumeni syndrome •Premenopausal breast cancer
•Leukaemia
•Brain tumours
•Adrenocortical carcinoma
•Lung bronchoalveolar cancer
Colon and endometrial cancers Lynch syndrome •Colon cancer
Colon and ovarian cancers HNPCC •Endometrial cancer

•Ovarian cancer
•Renal pelvis cancers
•Ureteral cancers
•Pancreatic and hepatobiliary cancers
•Stomach and small bowel cancers
Multiple colon polpys and/or colon cancer Familial adenomatous polyposis •Colon cancer
•Duodenal cancer
•Thyroid cancer
•Hepatoblastoma
Parathyroid adenomas and pituitary adenomas MEN1 •Pituitary tumours
•Parathyroid tumours
•Endocrine tumours of the gastro–entero–pancreatic tract
•Carcinoid tumours
Medullary thyroid cancer and phaeochromocytoma MEN 2 •Medullary thyroid cancer
•Phaeochromocytoma
•Parathyroid hyperplasia/adenoma

HNPCC, hereditary non-polyposis colon cancer; MEN1, multiple endocrine neoplasia type 1; MEN2, multiple endocrine neoplasia type 2; VHL, von Hippel-Lindau.

HHS Vulnerability Disclosure